Cannabigerol (CBG)
the non-intoxicating “mother cannabinoid”; the best-studied of this group.
Hub · the neutral minors
Minor cannabinoids
What are minor cannabinoids?
The short answer
Minor cannabinoids are the cannabinoids that cannabis makes in small amounts — essentially every cannabinoid other than the two most abundant, THC and CBD. They share the same chemical family but differ in structure, origin, and how much is actually known about them. Their chemical identities are established; for most of them, human evidence is thin or absent — a catalogue in progress, and we say so plainly rather than overstate.
Cannabigerol sits at the centre of this group: it is the “mother cannabinoid,” because its acid form (CBGA) is the shared precursor the plant converts into the others.
The minor cannabinoids we cover — identity is established; evidence status noted honestly:
Cannabichromene (CBC)
a non-intoxicating cannabinoid; pharmacology catalogue in progress.
Cannabinol (CBN)
forms as THC ages and oxidises; often marketed as a sleep aid, though controlled human studies have not established that effect.
Tetrahydrocannabivarin (THCV)
the propyl (varin) analog of THC; distinct receptor activity in lab studies.
Cannabigerovarin (CBGV)
the propyl analog of CBG; essentially no human data.
Cannabidivarin (CBDV)
the propyl analog of CBD; a completed Phase 2 randomised trial in focal seizures did not separate from placebo.
Cannabicyclol (CBL)
a light-driven (photodegradation) product of CBC; pharmacology catalogue in progress.
The acidic precursors of these compounds (CBGA and others) are covered in the cannabinoid acids; the propyl series has its own home in the varin cannabinoids.
The cannabinoid acids · The varin cannabinoids · How we grade evidence
Informational only — not our claims, and not advice
Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.